Nam Hoon Kim Selected Research

Triglycerides (Triacylglycerol)

11/2021	Association of the triglyceride and glucose index with low muscle mass: KNHANES 2008-2011.
1/2021	Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VII.
10/2018	Association of serum Sestrin2 level with metabolic risk factors in newly diagnosed drug-naïve type 2 diabetes.
11/2015	Vitamin D status and associated metabolic risk factors among North Korean refugees in South Korea: a cross-sectional study.
4/2014	Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nam Hoon Kim Research Topics

Disease

21	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2017
7	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 01/2018
6	Infections 05/2022 - 05/2005
6	Non-alcoholic Fatty Liver Disease 07/2021 - 04/2014
5	Chronic Kidney Failure (Chronic Renal Failure) 12/2021 - 01/2019
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2021 - 07/2013
5	Diabetes Mellitus 07/2021 - 01/2017
4	Myocardial Infarction 09/2022 - 01/2018
4	COVID-19 05/2022 - 01/2021
4	Ischemic Stroke 01/2022 - 01/2018
4	Insulin Resistance 11/2021 - 09/2018
4	Diabetes Complications 01/2021 - 12/2018
4	Stroke (Strokes) 01/2020 - 11/2017
4	Inflammation (Inflammations) 01/2020 - 05/2005
3	Dementia (Dementias) 11/2022 - 11/2017
3	Dyslipidemias (Dyslipidemia) 11/2022 - 12/2021
3	Albuminuria 01/2021 - 01/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2007 - 09/2003
2	Body Weight (Weight, Body) 01/2022 - 09/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 11/2019
2	Hypertension (High Blood Pressure) 12/2021 - 01/2021
2	Thyroid Neoplasms (Thyroid Cancer) 10/2020 - 10/2016
2	Heart Failure 01/2020 - 11/2019
2	Hypothyroidism 05/2019 - 10/2016
2	Atherosclerosis 01/2019 - 07/2013
2	Atrial Fibrillation 01/2019 - 11/2004
2	Neoplasms (Cancer) 11/2018 - 09/2005
2	Renal Insufficiency (Renal Failure) 01/2018 - 12/2006
2	Hepatocellular Carcinoma (Hepatoma) 10/2014 - 05/2005
2	Chronic Hepatitis B 09/2009 - 06/2004
1	Osteoporosis 09/2022
1	Thyroid Diseases (Thyroid Disease) 09/2022
1	Severe Fever with Thrombocytopenia Syndrome 07/2022
1	Communicable Diseases (Infectious Diseases) 07/2022
1	Peripheral Arterial Disease 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 12/2021
1	Uveal melanoma 12/2021
1	Eye Neoplasms (Eye Cancer) 12/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2021
1	Osteoporotic Fractures 09/2021
1	Hyperthyroidism 01/2021

Drug/Important Bio-Agent (IBA)

14	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 12/2009
5	Indicators and Reagents (Reagents)IBA 12/2021 - 11/2017
5	Triglycerides (Triacylglycerol)IBA 11/2021 - 04/2014
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 05/2017
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
4	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 06/2017
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2013
4	CholesterolIBA 01/2021 - 01/2019
4	Hypoglycemic Agents (Hypoglycemics)IBA 10/2019 - 05/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2019
3	Insulin (Novolin)FDA Link 12/2021 - 05/2017
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2007
3	Sodium-Glucose Transport ProteinsIBA 01/2021 - 01/2018
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 06/2017
3	C-Reactive ProteinIBA 10/2018 - 06/2017
2	CalciumIBA 09/2022 - 12/2009
2	Vitamin D FDA LinkGeneric 09/2022 - 11/2015
2	IodineIBA 09/2022 - 10/2020
2	VaccinesIBA 07/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 05/2022 - 05/2005
2	Antiviral Agents (Antivirals)IBA 01/2021 - 09/2009
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 10/2019
2	TransferasesIBA 01/2020 - 01/2020
2	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2019 - 10/2016
2	SteroidsIBA 05/2019 - 11/2007
2	CreatinineIBA 10/2018 - 12/2006
2	Alanine Transaminase (SGPT)IBA 10/2018 - 01/2018
2	EnzymesIBA 02/2018 - 01/2018
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2005 - 05/2005
2	CopperIBA 08/2004 - 09/2003
1	Blood Glucose (Blood Sugar)IBA 09/2022
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2022
1	Peptides (Polypeptides)IBA 07/2022
1	AntibodiesIBA 05/2022
1	Neutralizing AntibodiesIBA 05/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	empagliflozinIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	GlucosidasesIBA 12/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2021
1	Type C PhospholipasesIBA 12/2021
1	sarcoma-associated antigen S1IBA 01/2021
1	AntigensIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Interleukin-15 (Interleukin 15)IBA 01/2020

Therapy/Procedure

10	Therapeutics 07/2022 - 11/2004
3	Glycemic Control 01/2021 - 08/2017
2	Gastrectomy 01/2022 - 05/2006
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 11/2019
2	Aftercare (After-Treatment) 06/2017 - 11/2007
2	Enema (Enemas) 12/2009 - 02/2006
1	Duration of Therapy 01/2022
1	Fitness Trackers 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Continuous Renal Replacement Therapy 01/2021
1	Extracorporeal Membrane Oxygenation 01/2021